Doctor's Bag
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Precision Cancer Diagnostic Tests Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Precision Cancer Diagnostic Tests Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Imaging
1.2.3 Molecular
1.2.4 Histology/Cytology
1.2.5 Tumor Marker Immunoassays
1.2.6 POC Colon Cancer Tests
1.3 Market by Application
1.3.1 Global Precision Cancer Diagnostic Tests Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Precision Cancer Diagnostic Tests Market Perspective (2017-2028)
2.2 Precision Cancer Diagnostic Tests Growth Trends by Region
2.2.1 Precision Cancer Diagnostic Tests Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Precision Cancer Diagnostic Tests Historic Market Size by Region (2017-2022)
2.2.3 Precision Cancer Diagnostic Tests Forecasted Market Size by Region (2023-2028)
2.3 Precision Cancer Diagnostic Tests Market Dynamics
2.3.1 Precision Cancer Diagnostic Tests Industry Trends
2.3.2 Precision Cancer Diagnostic Tests Market Drivers
2.3.3 Precision Cancer Diagnostic Tests Market Challenges
2.3.4 Precision Cancer Diagnostic Tests Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Precision Cancer Diagnostic Tests Players by Revenue
3.1.1 Global Top Precision Cancer Diagnostic Tests Players by Revenue (2017-2022)
3.1.2 Global Precision Cancer Diagnostic Tests Revenue Market Share by Players (2017-2022)
3.2 Global Precision Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Precision Cancer Diagnostic Tests Revenue
3.4 Global Precision Cancer Diagnostic Tests Market Concentration Ratio
3.4.1 Global Precision Cancer Diagnostic Tests Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Precision Cancer Diagnostic Tests Revenue in 2021
3.5 Precision Cancer Diagnostic Tests Key Players Head office and Area Served
3.6 Key Players Precision Cancer Diagnostic Tests Product Solution and Service
3.7 Date of Enter into Precision Cancer Diagnostic Tests Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Precision Cancer Diagnostic Tests Breakdown Data by Type
4.1 Global Precision Cancer Diagnostic Tests Historic Market Size by Type (2017-2022)
4.2 Global Precision Cancer Diagnostic Tests Forecasted Market Size by Type (2023-2028)
5 Precision Cancer Diagnostic Tests Breakdown Data by Application
5.1 Global Precision Cancer Diagnostic Tests Historic Market Size by Application (2017-2022)
5.2 Global Precision Cancer Diagnostic Tests Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Precision Cancer Diagnostic Tests Market Size (2017-2028)
6.2 North America Precision Cancer Diagnostic Tests Market Size by Country (2017-2022)
6.3 North America Precision Cancer Diagnostic Tests Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Precision Cancer Diagnostic Tests Market Size (2017-2028)
7.2 Europe Precision Cancer Diagnostic Tests Market Size by Country (2017-2022)
7.3 Europe Precision Cancer Diagnostic Tests Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Precision Cancer Diagnostic Tests Market Size (2017-2028)
8.2 Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Country (2017-2022)
8.3 Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Precision Cancer Diagnostic Tests Market Size (2017-2028)
9.2 Latin America Precision Cancer Diagnostic Tests Market Size by Country (2017-2022)
9.3 Latin America Precision Cancer Diagnostic Tests Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Precision Cancer Diagnostic Tests Market Size (2017-2028)
10.2 Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Country (2017-2022)
10.3 Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Precision Cancer Diagnostic Tests Introduction
11.1.4 Abbott Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.1.5 Abbott Laboratories Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Detail
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Precision Cancer Diagnostic Tests Introduction
11.2.4 Agilent Technologies Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.2.5 Agilent Technologies Recent Development
11.3 Becton Dickinson and Company
11.3.1 Becton Dickinson and Company Company Detail
11.3.2 Becton Dickinson and Company Business Overview
11.3.3 Becton Dickinson and Company Precision Cancer Diagnostic Tests Introduction
11.3.4 Becton Dickinson and Company Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.3.5 Becton Dickinson and Company Recent Development
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Detail
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Introduction
11.4.4 Bio-Rad Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.4.5 Bio-Rad Laboratories Recent Development
11.5 Biocartis N.V.
11.5.1 Biocartis N.V. Company Detail
11.5.2 Biocartis N.V. Business Overview
11.5.3 Biocartis N.V. Precision Cancer Diagnostic Tests Introduction
11.5.4 Biocartis N.V. Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.5.5 Biocartis N.V. Recent Development
11.6 Biocept
11.6.1 Biocept Company Detail
11.6.2 Biocept Business Overview
11.6.3 Biocept Precision Cancer Diagnostic Tests Introduction
11.6.4 Biocept Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.6.5 Biocept Recent Development
11.7 bioMerieux SA
11.7.1 bioMerieux SA Company Detail
11.7.2 bioMerieux SA Business Overview
11.7.3 bioMerieux SA Precision Cancer Diagnostic Tests Introduction
11.7.4 bioMerieux SA Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.7.5 bioMerieux SA Recent Development
11.8 Canon Medical Systems Corporation
11.8.1 Canon Medical Systems Corporation Company Detail
11.8.2 Canon Medical Systems Corporation Business Overview
11.8.3 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Introduction
11.8.4 Canon Medical Systems Corporation Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.8.5 Canon Medical Systems Corporation Recent Development
11.9 Cynvenio Biosystems
11.9.1 Cynvenio Biosystems Company Detail
11.9.2 Cynvenio Biosystems Business Overview
11.9.3 Cynvenio Biosystems Precision Cancer Diagnostic Tests Introduction
11.9.4 Cynvenio Biosystems Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.9.5 Cynvenio Biosystems Recent Development
11.10 Danaher Corporation
11.10.1 Danaher Corporation Company Detail
11.10.2 Danaher Corporation Business Overview
11.10.3 Danaher Corporation Precision Cancer Diagnostic Tests Introduction
11.10.4 Danaher Corporation Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.10.5 Danaher Corporation Recent Development
11.11 Epigenomics AG
11.11.1 Epigenomics AG Company Detail
11.11.2 Epigenomics AG Business Overview
11.11.3 Epigenomics AG Precision Cancer Diagnostic Tests Introduction
11.11.4 Epigenomics AG Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.11.5 Epigenomics AG Recent Development
11.12 Exosome Diagnostics
11.12.1 Exosome Diagnostics Company Detail
11.12.2 Exosome Diagnostics Business Overview
11.12.3 Exosome Diagnostics Precision Cancer Diagnostic Tests Introduction
11.12.4 Exosome Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.12.5 Exosome Diagnostics Recent Development
11.13 Foundation Medicine
11.13.1 Foundation Medicine Company Detail
11.13.2 Foundation Medicine Business Overview
11.13.3 Foundation Medicine Precision Cancer Diagnostic Tests Introduction
11.13.4 Foundation Medicine Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.13.5 Foundation Medicine Recent Development
11.14 General Electric Company
11.14.1 General Electric Company Company Detail
11.14.2 General Electric Company Business Overview
11.14.3 General Electric Company Precision Cancer Diagnostic Tests Introduction
11.14.4 General Electric Company Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.14.5 General Electric Company Recent Development
11.15 Genomic Health
11.15.1 Genomic Health Company Detail
11.15.2 Genomic Health Business Overview
11.15.3 Genomic Health Precision Cancer Diagnostic Tests Introduction
11.15.4 Genomic Health Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.15.5 Genomic Health Recent Development
11.16 Hologic
11.16.1 Hologic Company Detail
11.16.2 Hologic Business Overview
11.16.3 Hologic Precision Cancer Diagnostic Tests Introduction
11.16.4 Hologic Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.16.5 Hologic Recent Development
11.17 Illumina
11.17.1 Illumina Company Detail
11.17.2 Illumina Business Overview
11.17.3 Illumina Precision Cancer Diagnostic Tests Introduction
11.17.4 Illumina Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.17.5 Illumina Recent Development
11.18 Menarini Silicon Biosystems SpA
11.18.1 Menarini Silicon Biosystems SpA Company Detail
11.18.2 Menarini Silicon Biosystems SpA Business Overview
11.18.3 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Introduction
11.18.4 Menarini Silicon Biosystems SpA Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.18.5 Menarini Silicon Biosystems SpA Recent Development
11.19 Myriad Genetics
11.19.1 Myriad Genetics Company Detail
11.19.2 Myriad Genetics Business Overview
11.19.3 Myriad Genetics Precision Cancer Diagnostic Tests Introduction
11.19.4 Myriad Genetics Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.19.5 Myriad Genetics Recent Development
11.20 NanoString Technologies
11.20.1 NanoString Technologies Company Detail
11.20.2 NanoString Technologies Business Overview
11.20.3 NanoString Technologies Precision Cancer Diagnostic Tests Introduction
11.20.4 NanoString Technologies Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.20.5 NanoString Technologies Recent Development
11.21 Ortho Clinical Diagnostics
11.21.1 Ortho Clinical Diagnostics Company Detail
11.21.2 Ortho Clinical Diagnostics Business Overview
11.21.3 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Introduction
11.21.4 Ortho Clinical Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.21.5 Ortho Clinical Diagnostics Recent Development
11.22 QIAGEN N.V.
11.22.1 QIAGEN N.V. Company Detail
11.22.2 QIAGEN N.V. Business Overview
11.22.3 QIAGEN N.V. Precision Cancer Diagnostic Tests Introduction
11.22.4 QIAGEN N.V. Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.22.5 QIAGEN N.V. Recent Development
11.23 Randox Laboratories Ltd.
11.23.1 Randox Laboratories Ltd. Company Detail
11.23.2 Randox Laboratories Ltd. Business Overview
11.23.3 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Introduction
11.23.4 Randox Laboratories Ltd. Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.23.5 Randox Laboratories Ltd. Recent Development
11.24 Roche Holding AG
11.24.1 Roche Holding AG Company Detail
11.24.2 Roche Holding AG Business Overview
11.24.3 Roche Holding AG Precision Cancer Diagnostic Tests Introduction
11.24.4 Roche Holding AG Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.24.5 Roche Holding AG Recent Development
11.25 Royal Philips N.V.
11.25.1 Royal Philips N.V. Company Detail
11.25.2 Royal Philips N.V. Business Overview
11.25.3 Royal Philips N.V. Precision Cancer Diagnostic Tests Introduction
11.25.4 Royal Philips N.V. Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.25.5 Royal Philips N.V. Recent Development
11.26 Siemens AG
11.26.1 Siemens AG Company Detail
11.26.2 Siemens AG Business Overview
11.26.3 Siemens AG Precision Cancer Diagnostic Tests Introduction
11.26.4 Siemens AG Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.26.5 Siemens AG Recent Development
11.27 Thermo Fisher Scientific
11.27.1 Thermo Fisher Scientific Company Detail
11.27.2 Thermo Fisher Scientific Business Overview
11.27.3 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Introduction
11.27.4 Thermo Fisher Scientific Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.27.5 Thermo Fisher Scientific Recent Development
11.28 Vela Diagnostics
11.28.1 Vela Diagnostics Company Detail
11.28.2 Vela Diagnostics Business Overview
11.28.3 Vela Diagnostics Precision Cancer Diagnostic Tests Introduction
11.28.4 Vela Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.28.5 Vela Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Precision Cancer Diagnostic Tests Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Imaging
Table 3. Key Players of Molecular
Table 4. Key Players of Histology/Cytology
Table 5. Key Players of Tumor Marker Immunoassays
Table 6. Key Players of POC Colon Cancer Tests
Table 7. Global Precision Cancer Diagnostic Tests Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Precision Cancer Diagnostic Tests Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Precision Cancer Diagnostic Tests Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Precision Cancer Diagnostic Tests Market Share by Region (2017-2022)
Table 11. Global Precision Cancer Diagnostic Tests Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Precision Cancer Diagnostic Tests Market Share by Region (2023-2028)
Table 13. Precision Cancer Diagnostic Tests Market Trends
Table 14. Precision Cancer Diagnostic Tests Market Drivers
Table 15. Precision Cancer Diagnostic Tests Market Challenges
Table 16. Precision Cancer Diagnostic Tests Market Restraints
Table 17. Global Precision Cancer Diagnostic Tests Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Precision Cancer Diagnostic Tests Market Share by Players (2017-2022)
Table 19. Global Top Precision Cancer Diagnostic Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Diagnostic Tests as of 2021)
Table 20. Ranking of Global Top Precision Cancer Diagnostic Tests Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Precision Cancer Diagnostic Tests Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Precision Cancer Diagnostic Tests Product Solution and Service
Table 24. Date of Enter into Precision Cancer Diagnostic Tests Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Precision Cancer Diagnostic Tests Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Precision Cancer Diagnostic Tests Revenue Market Share by Type (2017-2022)
Table 28. Global Precision Cancer Diagnostic Tests Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Precision Cancer Diagnostic Tests Revenue Market Share by Type (2023-2028)
Table 30. Global Precision Cancer Diagnostic Tests Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Precision Cancer Diagnostic Tests Revenue Market Share by Application (2017-2022)
Table 32. Global Precision Cancer Diagnostic Tests Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Precision Cancer Diagnostic Tests Revenue Market Share by Application (2023-2028)
Table 34. North America Precision Cancer Diagnostic Tests Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Precision Cancer Diagnostic Tests Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Precision Cancer Diagnostic Tests Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Precision Cancer Diagnostic Tests Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Precision Cancer Diagnostic Tests Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Precision Cancer Diagnostic Tests Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Country (2023-2028) & (US$ Million)
Table 44. Abbott Laboratories Company Detail
Table 45. Abbott Laboratories Business Overview
Table 46. Abbott Laboratories Precision Cancer Diagnostic Tests Product
Table 47. Abbott Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 48. Abbott Laboratories Recent Development
Table 49. Agilent Technologies Company Detail
Table 50. Agilent Technologies Business Overview
Table 51. Agilent Technologies Precision Cancer Diagnostic Tests Product
Table 52. Agilent Technologies Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 53. Agilent Technologies Recent Development
Table 54. Becton Dickinson and Company Company Detail
Table 55. Becton Dickinson and Company Business Overview
Table 56. Becton Dickinson and Company Precision Cancer Diagnostic Tests Product
Table 57. Becton Dickinson and Company Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 58. Becton Dickinson and Company Recent Development
Table 59. Bio-Rad Laboratories Company Detail
Table 60. Bio-Rad Laboratories Business Overview
Table 61. Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product
Table 62. Bio-Rad Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 63. Bio-Rad Laboratories Recent Development
Table 64. Biocartis N.V. Company Detail
Table 65. Biocartis N.V. Business Overview
Table 66. Biocartis N.V. Precision Cancer Diagnostic Tests Product
Table 67. Biocartis N.V. Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 68. Biocartis N.V. Recent Development
Table 69. Biocept Company Detail
Table 70. Biocept Business Overview
Table 71. Biocept Precision Cancer Diagnostic Tests Product
Table 72. Biocept Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 73. Biocept Recent Development
Table 74. bioMerieux SA Company Detail
Table 75. bioMerieux SA Business Overview
Table 76. bioMerieux SA Precision Cancer Diagnostic Tests Product
Table 77. bioMerieux SA Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 78. bioMerieux SA Recent Development
Table 79. Canon Medical Systems Corporation Company Detail
Table 80. Canon Medical Systems Corporation Business Overview
Table 81. Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Product
Table 82. Canon Medical Systems Corporation Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 83. Canon Medical Systems Corporation Recent Development
Table 84. Cynvenio Biosystems Company Detail
Table 85. Cynvenio Biosystems Business Overview
Table 86. Cynvenio Biosystems Precision Cancer Diagnostic Tests Product
Table 87. Cynvenio Biosystems Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 88. Cynvenio Biosystems Recent Development
Table 89. Danaher Corporation Company Detail
Table 90. Danaher Corporation Business Overview
Table 91. Danaher Corporation Precision Cancer Diagnostic Tests Product
Table 92. Danaher Corporation Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 93. Danaher Corporation Recent Development
Table 94. Epigenomics AG Company Detail
Table 95. Epigenomics AG Business Overview
Table 96. Epigenomics AG Precision Cancer Diagnostic TestsProduct
Table 97. Epigenomics AG Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 98. Epigenomics AG Recent Development
Table 99. Exosome Diagnostics Company Detail
Table 100. Exosome Diagnostics Business Overview
Table 101. Exosome Diagnostics Precision Cancer Diagnostic TestsProduct
Table 102. Exosome Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 103. Exosome Diagnostics Recent Development
Table 104. Foundation Medicine Company Detail
Table 105. Foundation Medicine Business Overview
Table 106. Foundation Medicine Precision Cancer Diagnostic TestsProduct
Table 107. Foundation Medicine Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 108. Foundation Medicine Recent Development
Table 109. General Electric Company Company Detail
Table 110. General Electric Company Business Overview
Table 111. General Electric Company Precision Cancer Diagnostic TestsProduct
Table 112. General Electric Company Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 113. General Electric Company Recent Development
Table 114. Genomic Health Company Detail
Table 115. Genomic Health Business Overview
Table 116. Genomic Health Precision Cancer Diagnostic TestsProduct
Table 117. Genomic Health Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 118. Genomic Health Recent Development
Table 119. Hologic Company Detail
Table 120. Hologic Business Overview
Table 121. Hologic Precision Cancer Diagnostic TestsProduct
Table 122. Hologic Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 123. Hologic Recent Development
Table 124. Illumina Company Detail
Table 125. Illumina Business Overview
Table 126. Illumina Precision Cancer Diagnostic TestsProduct
Table 127. Illumina Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 128. Illumina Recent Development
Table 129. Menarini Silicon Biosystems SpA Company Detail
Table 130. Menarini Silicon Biosystems SpA Business Overview
Table 131. Menarini Silicon Biosystems SpA Precision Cancer Diagnostic TestsProduct
Table 132. Menarini Silicon Biosystems SpA Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 133. Menarini Silicon Biosystems SpA Recent Development
Table 134. Myriad Genetics Company Detail
Table 135. Myriad Genetics Business Overview
Table 136. Myriad Genetics Precision Cancer Diagnostic TestsProduct
Table 137. Myriad Genetics Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 138. Myriad Genetics Recent Development
Table 139. NanoString Technologies Company Detail
Table 140. NanoString Technologies Business Overview
Table 141. NanoString Technologies Precision Cancer Diagnostic TestsProduct
Table 142. NanoString Technologies Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 143. NanoString Technologies Recent Development
Table 144. Ortho Clinical Diagnostics Company Detail
Table 145. Ortho Clinical Diagnostics Business Overview
Table 146. Ortho Clinical Diagnostics Precision Cancer Diagnostic TestsProduct
Table 147. Ortho Clinical Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 148. Ortho Clinical Diagnostics Recent Development
Table 149. QIAGEN N.V. Company Detail
Table 150. QIAGEN N.V. Business Overview
Table 151. QIAGEN N.V. Precision Cancer Diagnostic TestsProduct
Table 152. QIAGEN N.V. Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 153. QIAGEN N.V. Recent Development
Table 154. Randox Laboratories Ltd. Company Detail
Table 155. Randox Laboratories Ltd. Business Overview
Table 156. Randox Laboratories Ltd. Precision Cancer Diagnostic TestsProduct
Table 157. Randox Laboratories Ltd. Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 158. Randox Laboratories Ltd. Recent Development
Table 159. Roche Holding AG Company Detail
Table 160. Roche Holding AG Business Overview
Table 161. Roche Holding AG Precision Cancer Diagnostic TestsProduct
Table 162. Roche Holding AG Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 163. Roche Holding AG Recent Development
Table 164. Royal Philips N.V. Company Detail
Table 165. Royal Philips N.V. Business Overview
Table 166. Royal Philips N.V. Precision Cancer Diagnostic TestsProduct
Table 167. Royal Philips N.V. Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 168. Royal Philips N.V. Recent Development
Table 169. Siemens AG Company Detail
Table 170. Siemens AG Business Overview
Table 171. Siemens AG Precision Cancer Diagnostic TestsProduct
Table 172. Siemens AG Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 173. Siemens AG Recent Development
Table 174. Thermo Fisher Scientific Company Detail
Table 175. Thermo Fisher Scientific Business Overview
Table 176. Thermo Fisher Scientific Precision Cancer Diagnostic TestsProduct
Table 177. Thermo Fisher Scientific Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 178. Thermo Fisher Scientific Recent Development
Table 179. Vela Diagnostics Company Detail
Table 180. Vela Diagnostics Business Overview
Table 181. Vela Diagnostics Precision Cancer Diagnostic TestsProduct
Table 182. Vela Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 183. Vela Diagnostics Recent Development
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Precision Cancer Diagnostic Tests Market Share by Type: 2021 VS 2028
Figure 2. Imaging Features
Figure 3. Molecular Features
Figure 4. Histology/Cytology Features
Figure 5. Tumor Marker Immunoassays Features
Figure 6. POC Colon Cancer Tests Features
Figure 7. Global Precision Cancer Diagnostic Tests Market Share by Application in 2021 & 2028
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Other Case Studies
Figure 11. Precision Cancer Diagnostic Tests Report Years Considered
Figure 12. Global Precision Cancer Diagnostic Tests Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Precision Cancer Diagnostic Tests Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Precision Cancer Diagnostic Tests Market Share by Region: 2021 VS 2028
Figure 15. Global Precision Cancer Diagnostic Tests Market Share by Players in 2021
Figure 16. Global Top Precision Cancer Diagnostic Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Diagnostic Tests as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Precision Cancer Diagnostic Tests Revenue in 2021
Figure 18. North America Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America Precision Cancer Diagnostic Tests Market Share by Country (2017-2028)
Figure 20. United States Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Precision Cancer Diagnostic Tests Market Share by Country (2017-2028)
Figure 24. Germany Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Precision Cancer Diagnostic Tests Market Share by Region (2017-2028)
Figure 32. China Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Precision Cancer Diagnostic Tests Market Share by Country (2017-2028)
Figure 40. Mexico Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Precision Cancer Diagnostic Tests Market Share by Country (2017-2028)
Figure 44. Turkey Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Abbott Laboratories Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 47. Agilent Technologies Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 48. Becton Dickinson and Company Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 49. Bio-Rad Laboratories Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 50. Biocartis N.V. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 51. Biocept Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 52. bioMerieux SA Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 53. Canon Medical Systems Corporation Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 54. Cynvenio Biosystems Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 55. Danaher Corporation Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 56. Epigenomics AG Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 57. Exosome Diagnostics Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 58. Foundation Medicine Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 59. General Electric Company Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 60. Genomic Health Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 61. Hologic Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 62. Illumina Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 63. Menarini Silicon Biosystems SpA Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 64. Myriad Genetics Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 65. NanoString Technologies Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 66. Ortho Clinical Diagnostics Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 67. QIAGEN N.V. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 68. Randox Laboratories Ltd. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 69. Roche Holding AG Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 70. Royal Philips N.V. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 71. Siemens AG Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 72. Thermo Fisher Scientific Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 73. Vela Diagnostics Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Laboratories Agilent Technologies Becton Dickinson and Company Bio-Rad Laboratories Biocartis N.V. Biocept bioMerieux SA Canon Medical Systems Corporation Cynvenio Biosystems Danaher Corporation Epigenomics AG Exosome Diagnostics Foundation Medicine General Electric Company Genomic Health Hologic Illumina Menarini Silicon Biosystems SpA Myriad Genetics NanoString Technologies Ortho Clinical Diagnostics QIAGEN N.V. Randox Laboratories Ltd. Roche Holding AG Royal Philips N.V. Siemens AG Thermo Fisher Scientific Vela Diagnostics